Single-Cell DNA Sequencing Reveals Punctuated and Gradual Clonal Evolution in Hepatocellular Carcinoma
Lin Guo,Xianfu Yi,Lu Chen,Ti Zhang,Hua Guo,Ziye Chen,Jinghui Cheng,Qi Cao,Hengkang Liu,Chunyu Hou,Lisha Qi,Zhiyan Zhu,Yucun Liu,Ruirui Kong,Chong Zhang,Xiaohua Zhou,Zemin Zhang,Tianqiang Song,Ruidong Xue,Ning Zhang
DOI: https://doi.org/10.1053/j.gastro.2021.08.052
IF: 29.4
2022-01-01
Gastroenterology
Abstract:Background & AimsCopy number alterations (CNAs), elicited by genome instability, is a major source of intratumor heterogeneity. How CNAs evolve in hepatocellular carcinoma (HCC) remains unknown.MethodsWe performed single cell DNA sequencing (scDNA-seq) on 1275 cells isolated from 10 HCC patients, ploidy-resolved scDNA-seq of 356 cells from 1 additional patient, and single cell RNA sequencing (scRNA-seq) on 27344 cells from 3 additional patients. Three statistical fitting models were compared to investigate the CNA accumulation pattern.ResultsCells in the tumor were categorized into three subpopulations: euploid, pseudoeuploid, and aneuploid. Our scDNA-seq analysis revealed that CNA accumulation followed a dual-phase copy number evolution (DPCNE) model, i.e. a punctuated phase followed by a gradual phase. Patients exhibited prolonged gradual phase showed higher intratumor heterogeneity and worse disease-free survival. Integrating bulk RNA-seq of 17 HCC patients, published datasets of 1196 liver tumors, and immunohistochemical staining of 202 HCC tumors, we showed that high expression of CAD, a gene involved in pyrimidine synthesis, was correlated with rapid tumorigenesis and reduced survival. The DPCNE model was validated by our scRNA-seq data and published scDNA-seq datasets of other cancer types. Furthermore, ploidy-resolved scDNA-seq revealed the common clonal origin of diploid- and polyploid-aneuploid cells, suggesting that polyploid tumor cells were generated by whole genome doubling of diploid tumor cells.ConclusionsOur work revealed a novel DPCNE model, showed HCC with longer gradual phase were more severe, identified CAD as a promising biomarker for early recurrence of HCC, and supported the diploid origin of polyploid HCC.
gastroenterology & hepatology